Annual report pursuant to Section 13 and 15(d)

Accrued Expenses (Tables)

v3.8.0.1
Accrued Expenses (Tables)
 12 Months Ended
Dec. 31, 2017
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following:

 

    December 31,  
    2017     2016  
Accrued clinical operations and trials costs   $ 2,003,799     $ 1,647,490  
Accrued product development costs     1,255,439       713,426  
Accrued compensation     1,335,672       778,250  
Accrued other     146,609       117,289  
Total   $ 4,741,519     $ 3,256,455